Zhaoke Ophthalmology Selected as a Presenting Company at the Eyecelerator@AAO 2021 Conference
2021-11-15
Zhaoke Ophthalmology Announces Full Results of Pivotal Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for the Treatment of Dry Eye Disease
2021-11-01
Zhaoke Ophthalmology appoints PharmaLogic Development Inc. as Regulatory Consultant for Product Development in North America
2021-10-26
First Patient Enrolled for the Investigator-Initiated trial of Zhaoke Ophthalmology’s ZKY001, for the Treatment of Neurotrophic Keratitis
2021-10-22
Zhaoke Ophthalmology Named as a “China Top 30 Innovative Small Molecule Drug Developer” on the “2020 China Top 100 Innovative Biotech Companies List”
2021-09-30
Zhaoke Ophthalmology’s IND Application for Potential First Myopia Drug to Market in China and Globally, NVK-002, Approved for Phase III Clinical Trial by the CDE
2021-09-29
Adapalene Clindamycin Hydrochloride Combination Gel Passing The On-Site Inspection For Drug Registration In China
2021-09-13